tetranor-PGDM
tetranor-PGDM structure
|
Common Name | tetranor-PGDM | ||
|---|---|---|---|---|
| CAS Number | 70803-91-7 | Molecular Weight | 328.358 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 622.2±50.0 °C at 760 mmHg | |
| Molecular Formula | C16H24O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 344.1±26.6 °C | |
Use of tetranor-PGDMTetranor-PGDM is an abundant urinary metabolite reflects biosynthesis of prostaglandin D2[1]. |
| Name | tetranor-PGDM |
|---|---|
| Synonym | More Synonyms |
| Description | Tetranor-PGDM is an abundant urinary metabolite reflects biosynthesis of prostaglandin D2[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 622.2±50.0 °C at 760 mmHg |
| Molecular Formula | C16H24O7 |
| Molecular Weight | 328.358 |
| Flash Point | 344.1±26.6 °C |
| Exact Mass | 328.152191 |
| PSA | 128.97000 |
| LogP | -1.38 |
| Vapour Pressure | 0.0±4.1 mmHg at 25°C |
| Index of Refraction | 1.522 |
|
~50%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; Location in patent: Page/Page column 21 ; |
|
~%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
|
~%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
|
~%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
|
~%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
|
~%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
|
~%
tetranor-PGDM CAS#:70803-91-7 |
| Literature: CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
CAS#:1352751-83-7| Cyclopentaneoctanoic acid, 2-(2-carboxyethyl)-3-hydroxy-ε,5-dioxo-, (1R,2R,3S)- |
| tetranor-prostaglandin D metabolite |
| 8-[(1R,2R,3S)-2-(2-Carboxyethyl)-3-hydroxy-5-oxocyclopentyl]-6-oxooctanoic acid |
| tetranor-prostaglandin A metabolite |